<DOC>
	<DOCNO>NCT01692886</DOCNO>
	<brief_summary>This study primarily design evaluate IgG immune responses 13 pneumococcal serotypes induce 13vPnC compare immune response induce 7vPnC measure 1 month infant series , evaluate acceptability safety profile 13vPnC measure incidence rate local reaction , systemic event adverse event .</brief_summary>
	<brief_title>A Study Evaluating 13-Valent Pneumococcal Conjugate Vaccine ( 13vPnC ) In Healthy Infants In China</brief_title>
	<detailed_description />
	<mesh_term>Pneumococcal Infections</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Heptavalent Pneumococcal Conjugate Vaccine</mesh_term>
	<criteria>1 . Aged 42 77 day ( approximately 2 month ) time enrollment . 2 . Healthy infant determine medical history , physical examination , judgment investigator . 1 . Previous vaccination license investigational pneumococcal vaccine . 2 . A previous anaphylactic reaction vaccine vaccinerelated component . 3 . Contraindication vaccination pneumococcal vaccine .</criteria>
	<gender>All</gender>
	<minimum_age>42 Days</minimum_age>
	<maximum_age>77 Days</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>13vPnC</keyword>
	<keyword>7vPnC</keyword>
	<keyword>Healthy subject</keyword>
	<keyword>China</keyword>
</DOC>